Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Brincidofovir in Hepatic Impairment
NCT05391724Phase 1Completed
- Sponsor
- Chimerix Inc.
- Start
- Feb 2011
- Primary completion
- Sep 2011
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label trial of brincidofovir in smallpox, cytomegalovirus infection (CMV) and adenovirus infection, sponsored by Chimerix Inc. Started Feb 2011; status: completed.
02
Drugs
brincidofovir
03
Conditions
smallpoxcytomegalovirus infection (CMV)adenovirus infection
Beyond the preview
Go deeper on NCT05391724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05391724.